MariMed Inc.
MRMD
$0.093
-$0.002-2.11%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -3.91% | 0.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.91% | 0.38% | |||
| Cost of Revenue | 10.41% | 1.21% | |||
| Gross Profit | -24.25% | -0.77% | |||
| SG&A Expenses | -7.29% | -3.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.55% | -0.64% | |||
| Operating Income | -173.58% | 31.01% | |||
| Income Before Tax | -856.76% | 56.02% | |||
| Income Tax Expenses | 655.42% | -24.36% | |||
| Earnings from Continuing Operations | -724.22% | 39.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 81.25% | -33.33% | |||
| Net Income | -711.47% | 38.76% | |||
| EBIT | -173.58% | 31.01% | |||
| EBITDA | -59.39% | 6.62% | |||
| EPS Basic | -696.30% | 38.64% | |||
| Normalized Basic EPS | -- | 100.00% | |||
| EPS Diluted | -696.30% | 38.64% | |||
| Normalized Diluted EPS | -- | 100.00% | |||
| Average Basic Shares Outstanding | 0.17% | 0.29% | |||
| Average Diluted Shares Outstanding | 0.17% | 0.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||